Actively Recruiting
Follow-up Study of Individuals with Autoantibodies Against Ro/SSA and La/SSB
Led by Karolinska Institutet · Updated on 2024-09-19
500
Participants Needed
1
Research Sites
772 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, individuals with autoantibodies against Ro/SSA and La/SSB will be followed with regard to clinical manifestations and immunological parameters to identify immunological changes, environmental factors, and early clinical symptoms that characterize the progression from serological autoreactivity to clinically manifest disease.
CONDITIONS
Official Title
Follow-up Study of Individuals with Autoantibodies Against Ro/SSA and La/SSB
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least one positive test for Ro/SSA or La/SSB autoantibodies for the risk group
- No rheumatologic disease and no autoantibodies against Ro/SSA or La/SSB for the control group
- 18 years of age or older
You will not qualify if you...
- Under 18 years of age
- Unable to consent to participation
- Ongoing infection or severe illness making participation unsafe
- Unable to read and understand Swedish to complete study forms and questionnaires
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centrum för reumatologi
Stockholm, Sweden
Actively Recruiting
Research Team
A
Albin Björk, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here